Compile Data Set for Download or QSAR
Found 46 Enz. Inhib. hit(s) with all data for entry = 3163
TargetCytochrome P450 26B1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50253810(CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1...)copy SMILEScopy InChI
Affinity DataIC50: 0.460nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393281(US9963439, R116010)copy SMILEScopy InChI
Affinity DataIC50: 3.10nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393281(US9963439, R116010)copy SMILEScopy InChI
Affinity DataIC50: 4.30nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50253810(CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1...)copy SMILEScopy InChI
Affinity DataIC50: 5.10nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157605(Liarozole | Liazal | R-75251 | US9963439, Liarozol...)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM151585(US11739089, Compound Ketoconazole | US8987315, Ket...)copy SMILEScopy InChI
Affinity DataIC50: 20nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393281(US9963439, R116010)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393290(DDBEP | US9963439, Tazarotenic acid)copy SMILEScopy InChI
Affinity DataIC50: 140nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26B1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM151585(US11739089, Compound Ketoconazole | US8987315, Ket...)copy SMILEScopy InChI
Affinity DataIC50: 140nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C8(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50253810(CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1...)copy SMILEScopy InChI
Affinity DataIC50: 220nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50253810(CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1...)copy SMILEScopy InChI
Affinity DataIC50: 470nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C8(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157605(Liarozole | Liazal | R-75251 | US9963439, Liarozol...)copy SMILEScopy InChI
Affinity DataIC50: 480nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM151585(US11739089, Compound Ketoconazole | US8987315, Ket...)copy SMILEScopy InChI
Affinity DataIC50: 660nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US PatentDrugBank
TargetCytochrome P450 2C9(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50253810(CHEMBL459505 | N-(4-(2-ethyl-1-(1H-1,2,4-triazol-1...)copy SMILEScopy InChI
Affinity DataIC50: 680nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157724(CHEMBL3787564 | US9963439, Compound B)copy SMILEScopy InChI
Affinity DataIC50: 1.01E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50265920(4-((5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthal...)copy SMILEScopy InChI
Affinity DataIC50: 1.22E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393295(US9963439, Compound F)copy SMILEScopy InChI
Affinity DataIC50: 1.25E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C8(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM151585(US11739089, Compound Ketoconazole | US8987315, Ket...)copy SMILEScopy InChI
Affinity DataIC50: 1.56E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US PatentDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393294(US9963439, Compound E)copy SMILEScopy InChI
Affinity DataIC50: 1.58E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157605(Liarozole | Liazal | R-75251 | US9963439, Liarozol...)copy SMILEScopy InChI
Affinity DataIC50: 1.63E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157731(CHEMBL3785511 | US9963439, Compound C)copy SMILEScopy InChI
Affinity DataIC50: 1.69E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C8(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393281(US9963439, R116010)copy SMILEScopy InChI
Affinity DataIC50: 1.76E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157605(Liarozole | Liazal | R-75251 | US9963439, Liarozol...)copy SMILEScopy InChI
Affinity DataIC50: 1.90E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50052414(4-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthale...)copy SMILEScopy InChI
Affinity DataIC50: 2.30E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM151585(US11739089, Compound Ketoconazole | US8987315, Ket...)copy SMILEScopy InChI
Affinity DataIC50: 2.57E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US PatentDrugBank
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393287(US9963439, Compound D)copy SMILEScopy InChI
Affinity DataIC50: 2.60E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393293(US9963439, Compound A)copy SMILEScopy InChI
Affinity DataIC50: 2.95E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50265951(CHEMBL1657 | TAZAROTENE | US9963439, Tazarotene | ...)copy SMILEScopy InChI
Affinity DataIC50: 3.15E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157731(CHEMBL3785511 | US9963439, Compound C)copy SMILEScopy InChI
Affinity DataIC50: 3.25E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50032219((E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydrona...)copy SMILEScopy InChI
Affinity DataIC50: 3.70E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393287(US9963439, Compound D)copy SMILEScopy InChI
Affinity DataIC50: 3.90E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157724(CHEMBL3787564 | US9963439, Compound B)copy SMILEScopy InChI
Affinity DataIC50: 4.40E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50032219((E)-4-(2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydrona...)copy SMILEScopy InChI
Affinity DataIC50: 5.60E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393281(US9963439, R116010)copy SMILEScopy InChI
Affinity DataIC50: 5.76E+3nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50052414(4-(1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphthale...)copy SMILEScopy InChI
Affinity DataIC50: 6.50E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393290(DDBEP | US9963439, Tazarotenic acid)copy SMILEScopy InChI
Affinity DataIC50: 7.60E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393295(US9963439, Compound F)copy SMILEScopy InChI
Affinity DataIC50: 9.90E+3nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50157605(Liarozole | Liazal | R-75251 | US9963439, Liarozol...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50265920(4-((5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthal...)copy SMILEScopy InChI
Affinity DataIC50: 1.05E+4nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50061625(4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthal...)copy SMILEScopy InChI
Affinity DataIC50: 1.07E+4nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM50061625(4-[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthal...)copy SMILEScopy InChI
Affinity DataIC50: 1.31E+4nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393289(US9963439, BMS961)copy SMILEScopy InChI
Affinity DataIC50: 1.48E+4nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM36810(BMS753 | US9963439, BMS753)copy SMILEScopy InChI
Affinity DataIC50: 2.90E+4nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393289(US9963439, BMS961)copy SMILEScopy InChI
Affinity DataIC50: 3.90E+4nMAssay Description:Compounds were assessed for inhibition (IC50, n=2) of CYP2C8, CYP2C9 and CYP3A4 in pooled human liver microsomes using selective probe substrates at ...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM36810(BMS753 | US9963439, BMS753)copy SMILEScopy InChI
Affinity DataIC50: 4.02E+4nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent
TargetCytochrome P450 26A1(Homo sapiens (Human))
University of Washington at Seattle

LigandPNGBDBM393294(US9963439, Compound E)copy SMILEScopy InChI
Affinity DataIC50: 4.25E+4nMAssay Description:Eighteen compounds were tested as potential inhibitors of CYP26A1 and CYP26B1. The formation of 9-cis-4-OH-RA metabolite was monitored and the percen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2FN18J2US Patent